NEUROG1 and hemorrhoid: In relation to the colorectal findings groups (Table 1), 0.00% (0.00–0.00%) median and IQR methylation of NEUROG1 resulted in individuals with no colorectal findings and all the benign pathology sub-groups (inflammatory and hyperplastic polyps, hemorrhoids, diverticula and other benign pathologies).